Fatal Moans and Bones in Crohn's: A Case of Heterotopic Mesenteric Ossification

Joyce Opara, Heather Jarrell1, Nicole R Jackson

  • 1New Mexico Office of the Medical Investigator, Albuquerque, NM.

Insights

Heterotopic mesenteric ossification (HMO) is a rare condition of abnormal bone formation in the mesentery. This case highlights HMO

Area of Science:

  • Gastroenterology
  • Pathology
  • Radiology

Background:

  • Heterotopic mesenteric ossification (HMO) is a rare reactive condition involving abnormal bone formation within the mesentery.
  • Its etiology is poorly understood, with theories suggesting trauma-induced metaplasia or surgical bone fragment dislodgment.
  • Fewer than 100 cases are documented, indicating a significant knowledge gap regarding this pathology.

Purpose of the Study:

  • To present a unique case of Heterotopic Mesenteric Ossification (HMO).
  • To discuss the diagnostic challenges and implications of HMO in patients with inflammatory bowel disease.
  • To emphasize the need for increased clinician awareness and interdisciplinary collaboration for improved patient outcomes.

Main Methods:

  • Case report of a 43-year-old male with severe Crohn's disease and multiple abdominal surgeries.
  • Clinical presentation, intensive care unit admission, and palliative care.
  • Autopsy findings revealing mesenteric bone fragments; review of antemortem imaging.

Main Results:

  • Autopsy confirmed mature, benign bone fragments in the mesentery, consistent with Heterotopic Mesenteric Ossification (HMO).
  • Antemortem imaging suggested HMO but was misinterpreted as contrast or calcification.
  • The patient experienced severe dehydration, likely due to decreased oral intake and ostomy-related medication cessation.

Conclusions:

  • This case highlights the importance of recognizing Heterotopic Mesenteric Ossification (HMO), especially in patients with inflammatory bowel disease.
  • Misinterpretation of imaging findings can delay diagnosis.
  • Early recognition and collaborative efforts among radiologists, pathologists, and clinicians are crucial for managing HMO and improving patient outcomes.